Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MNPR compared with PHVS: revenue, margins and what each company keeps, and the suppliers and customers both name
MNPR
Monopar Therapeutics
Change
Mkt cap
Revenue
Revenue
PHVS
Pharvaris N.V.
Change
Mkt cap
Revenue
Revenue
vs
Compare
MNPR
Monopar Therapeutics
vs
PHVS
Pharvaris N.V.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
MNPR: latest quarter not drawable. PHVS: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
MNPR, solid
PHVS, dashed
MNPR
Monopar Therapeutics
Change
69.99
▼
−2.66%
· post 69.99
Mkt cap
$472.0M
PHVS
Pharvaris N.V.
Change
33.53
▼
−0.13%
· post 34.68
Closed
Oct 30 '26
Mkt cap
$2.2B
vs
Compare
Closed
Oct 30 '26
MNPR
Monopar Therapeutics
vs
PHVS
Pharvaris N.V.
69.99
▼
−2.66%
post 69.99
Price
33.53
▼
−0.13%
post 34.68
$472.0M
Mkt cap
$2.2B
Change
Change
MNPR
69.99
▼
−2.66%
vs
PHVS
33.53
▼
−0.13%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only MNPR
2
AZN
AstraZeneca
supplier
—
NorthStar
unlisted
supplier
Shared
0
No shared counterparties.
Only PHVS
1
—
Brain
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR